GSK

GlaxoSmithKline targets 20MW solar project to decarbonise Scottish manufacturing website
Pharma huge GlaxoSmithKline (GSK) is targeting a 20MW solar project to assist power its production center in Irvine, Scotland.
Sep 23, 2021 // Plants, Large-Scale, Commercial, UK, Europe, GSK, decarbonise, Solar Project, Pharma huge GlaxoSmithKline
GSK to invest GBP 50m in new wind, solar farms at its factories
UK pharmaceutical company GlaxoSmithKline plc (LON: GSK) on Monday revealed that it will spend GBP 50 million (USD 68.4 m/EUR 58.3 m) in new wind and solar farms to power its manufacturing facilities, as part of the sector-wide dedication to reach net zero carbon exhausts by 2050.
Sep 21, 2021 // Markets & Finance News, UK, Europe, GSK
Major solar farm plan to power Angus pharmaceutical plant
Ambitious proposals have emerged to power a major Angus pharmaceutical plant with electricity from a giant solar farm on land a few miles away.
Oct 9, 2019 // Plants, Large-Scale, Commercial, UK, Europe, Angus, GSK, Proposal of Application Notice, Kate Cowey